The Immortal Life of Henrietta Lacks (25 page)

It is twenty-one years since George Gey established the famous HeLa cells in culture. It has been estimated that the weight of these cells in the world today exceeds that of the American negro from whose cervical tumour they originated. That lady has achieved true immortality, both in the test-tube and in the hearts and minds of scientists the world over, since the value of HeLa cells in research, diagnosis, etc., is inestimable. Yet we do not know her name! It has been widely stated that He and La are the first letters of her names but whereas one textbook says the names were Helen Lane another says Henrietta Lacks. My letters to the authors, inquiring the source of their information, like the letter to the hospital from which Gey’s paper emanated, remain unanswered. Does anyone know for sure? Would it be contrary to medical ethics in the HeLa cell’s coming-of-age year to authenticate the name and let He … La … enjoy the fame she so richly deserves?

Douglas was flooded with responses. There’s no record of readers addressing his question about medical ethics, but they did correct his grammar and his use of the word “negro” in place of “negress.” Many replies offered the names of women they believed were behind the HeLa cells: Helga Larsen, Heather Langtree, even the actress Hedy Lamarr. In a follow-up letter on April 20, 1973, Douglas announced that all those women should “withdraw as gracefully as they can,” because he’d received a letter from Howard W. Jones that left “no doubt that HeLa cells were named after Henrietta Lacks.”

And Jones wasn’t the only one setting the record straight about Henrietta’s name: soon Victor McKusick, one of Jones’s coauthors, would send a similar letter to a reporter from
Science
, correcting her misuse of the name Helen Lane. In response, the journalist wrote a short follow-up article in
Science
titled “HeLa (for Henrietta Lacks).” In it she explained that she’d inadvertently “repeated the lore about the origin of those cells.” Then, in one of the most widely read science journals in the world, she corrected her error: “Helen Lane, it seems, never lived. But Henrietta Lacks did, long protected by the pseudonym Helen Lane.” She also reported that Henrietta’s tumor had been incorrectly diagnosed.

“None of this alters the validity of the work done with HeLa cells,” she wrote, “but it may be worth noting—for the record.”

23
“It’s Alive”

O
n a hazy day in 1973, in a brown brick row house five doors down from her own, Bobbette Lacks sat at her friend Gardenia’s dining room table. Gardenia’s brother-in-law was in town from Washington, D.C., and they’d all just finished having lunch. As Gardenia clanked dishes in the kitchen, her brother-in-law asked Bobbette what she did for a living. When she told him she was a patient aide at Baltimore City Hospital, he said, “Really? I work at the National Cancer Institute.”

They talked about medicine and Gardenia’s plants, which covered the windows and counters. “Those things would die in my house,” Bobbette said, and they laughed.

“Where you from anyway?” he asked.

“North Baltimore.”

“No kidding, me too. What’s your last name?”

“Well, it was Cooper, but my married name is Lacks.”

“Your last name is Lacks?”

“Yeah, why?”

“It’s funny,” he said, “I’ve been working with these cells in my lab for years, and I just read this article that said they came from a woman named Henrietta Lacks. I’ve never heard that name anywhere else.”

Bobbette laughed. “My mother-in-law’s Henrietta Lacks but I know you’re not talking about her—she’s been dead almost twenty-five years.”

“Henrietta Lacks is your mother-in-law?” he asked, suddenly excited. “Did she die of cervical cancer?”

Bobbette stopped smiling and snapped, “How’d you know that?”

“Those cells in my lab have to be hers,” he said. “They’re from a black woman named Henrietta Lacks who died of cervical cancer at Hopkins in the fifties.”

“What?!” Bobbette yelled, jumping up from her chair. “What you mean you got her cells in your lab?”

He held his hands up, like
Whoa, wait a minute
. “I ordered them from a supplier just like everybody else.”

“What do you mean, ‘everybody else’?!” Bobbette snapped. “
What
supplier? Who’s got cells from my mother-in-law?”

It was like a nightmare. She’d read in the paper about the syphilis study at Tuskegee, which had just been stopped by the government after forty years, and now here was Gardenia’s brother-in-law, saying Hopkins had part of Henrietta alive and scientists everywhere were doing research on her and the family had no idea. It was like all those terrifying stories she’d heard about Hopkins her whole life were suddenly true, and happening to her.
If they’re doing research on Henrietta
, she thought,
it’s only a matter of time before they come for Henrietta’s children, and maybe her grandchildren
.

Gardenia’s brother-in-law told Bobbette that Henrietta’s cells had been all over the news lately because they’d been causing problems by contaminating other cultures. But Bobbette just kept shaking her head and saying, “How come nobody told her family part of her was still alive?”

“I wish I knew,” he said. Like most researchers, he’d never thought about whether the woman behind HeLa cells had given them voluntarily.

Bobbette excused herself and ran home, bursting through the screen door into the kitchen, yelling for Lawrence, “Part of your mother, it’s alive!”

Lawrence called his father to tell him what Bobbette had heard, and Day didn’t know what to think.
Henrietta’s alive?
he thought. It didn’t make any sense. He’d seen her body at the funeral in Clover himself. Did they go dig it up? Or maybe they did something to her during that autopsy?

Lawrence called the main switchboard at Hopkins, saying, “I’m calling about my mother, Henrietta Lacks—you got some of her alive in there.” When the operator couldn’t find a record of a patient named Henrietta Lacks in the hospital, Lawrence hung up and didn’t know who else to call.

     
S
oon after Lawrence called Hopkins, in June 1973, a group of researchers gathered around a table at Yale University at the First International Workshop on Human Gene Mapping, a first step toward the Human Genome Project. They were talking about how to stop the HeLa contamination problem, when someone pointed out that the whole mess could be sorted out if they found genetic markers specific to Henrietta and used them to identify which cells were hers and which weren’t. But doing that would require DNA samples from her immediate family—preferably her husband as well as her children—to compare their DNA to HeLa’s and create a map of Henrietta’s genes.

Victor McKusick, one of the scientists who’d first published Henrietta’s name, happened to be at that table. He told them he could help. Henrietta’s husband and children were still patients at Hopkins, he said, so finding them wouldn’t be difficult. As a physician on staff, McKusick had access to their medical records and contact information.

The geneticists at the conference were thrilled. If they had access to DNA from Henrietta’s children, they could not only solve the contamination problem but also study Henrietta’s cells in entirely new ways. McKusick agreed, so he turned to one of his postdoctoral fellows, Susan Hsu, and said, “As soon as you get back to Baltimore, get this done.”

McKusick didn’t give Hsu instructions for explaining the research to the Lackses. All she knew was that Victor McKusick had told her to call the family.

“He was like a god,” Hsu told me years later. “He was a famous, famous man, he trained most of the other famous medical geneticists in the world. When Dr. McKusick said, ‘You go back to Baltimore, get this blood drawn,’ I did it.”

When Hsu got home from the conference, she called Day to ask if she could draw blood from his family. “They said they got my wife and she part alive,” he told me years later. “They said they been doin experiments on her and they wanted to come test my children see if they got that cancer killed their mother.”

But Hsu hadn’t said anything about testing the children for cancer. There was no such thing as a “cancer test,” and even if there had been, McKusick’s lab wouldn’t have been doing one, because he wasn’t a cancer researcher. McKusick was a renowned geneticist who’d founded the world’s first human genetics department at Hopkins, where he maintained a catalog of hundreds of genes, including several he’d discovered himself in Amish populations. He compiled information about known genes and the research done on them into a database called
Mendelian Inheritance in Man
, the bible of the field, which now has nearly twenty thousand entries and is still growing.

McKusick and Hsu were hoping to use somatic-cell hybridization to test the Lacks family for several different genetic markers, including specific proteins called
HLA markers
. By testing Henrietta’s children, they hoped to find out what Henrietta’s HLA markers might have been, so they could use those to identify her cells.

Hsu had only recently come to America from China, and English wasn’t her native language. According to Hsu, when she called Day in 1973, she told him this: “We come to draw blood to get HLA antigen, we do genetic marker profile because we can deduce a lot of Henrietta Lacks genotype from the children and the husband.”

When I asked her if Day seemed to understand, Hsu said, “They are very receptible to us when I made phone call. They are pretty intelligent. I think Mr. Lacks pretty much already knew that his wife made a contribution and are very aware of the value of HeLa cells. They probably heard people talking that the cell line is such important thing. Everybody talking about HeLa back then. They are a very nice family, so they very nicely let us draw blood.”

Hsu’s accent was strong, and so was Day’s—he spoke with a Southern country drawl so thick his own children often had a hard time understanding him. But language wasn’t their only barrier. Day wouldn’t have understood the concept of immortal cells or HLA markers coming from anyone, accent or not—he’d only gone to school for four years of his life, and he’d never studied science. The only kind of cell he’d heard of was the kind Zakariyya was living in out at Hagerstown. So he did what he’d always done when he didn’t understand something a doctor said: he nodded and said yes.

Years later, when I asked McKusick if anyone had tried to get informed consent from the Lacks family, he said, “I suspect there was no effort to explain anything in great detail. But I don’t believe anyone would have told them we were testing for cancer because that wasn’t the case. They would have just said, ‘Your mother had cancer, the cells from that cancer have been growing all over the place and studied in great detail, in order to understand that better, we would like to have that blood from you people.’ “

When I asked Susan Hsu the same question she said, “No. We never gave consent form because you just go to draw blood. We are not doing some kind of medical research, you know, not long term. All we wanted is a few tubes of blood and to do genetic marker test. It’s not involved in a human research committee or things like that.”

Although this attitude wasn’t uncommon at the time, NIH guidelines stipulated that all human subject research funded by NIH—as McKusick’s was—required both informed consent and approval from a Hopkins review board. Those guidelines had been implemented in 1966, in the aftermath of the Southam trial, and then expanded to include a detailed definition of informed consent in 1971. They were in the process of being codified into law when Hsu called Day.

McKusick began his research on the Lacks family at a time of great flux in research oversight. Just one year earlier, in response to Tuskegee and several other unethical studies, the Department of Health, Education, and Welfare (HEW) had launched an investigation into federal oversight of human-subject research and found it to be inadequate. As one government report said, it was a time filled with “widespread confusion about how to assess risk,” as well as “refusal by some researchers to cooperate” with oversight, and “indifference by those charged with administering research and its rules at local institutions.” After halting the Tuskegee study, HEW proposed new Protection of Human Subjects regulations that would require, among other things, informed consent. A notice inviting public comment on that proposed new law would be published in the
Federal Register
in October 1973, just a few months after Hsu called Day.